Such compounds include little or huge molecule therapeutics for both systemic and local applications. These devices promises to end up being the 1st completely electronic DPI in the marketplace and represents another generation in inhaler technology both in performance and simplicity for patients. Commenting on the transaction, Anand Gumaste, president and ceo, MicroDose, stated, ‘Through this collaboration, MicroDose will be able to offer the pharmaceutical and biotechnology industries a completely integrated inhalation product advancement and manufacturing capability. We are pleased to end up being partnering with 3M to make this happen.’ Scott Fleming, senior vice president of advertising, MicroDose, added ‘By merging our innovative inhaler technology system with 3M’s verified leadership in health care products and solid brand, we will create a dynamic partnership providing exclusive inhalation product solutions for an expanded market.’ MicroDose and 3M presently would like business alliances with pharmaceutical and biotechnology companies thinking about the pulmonary delivery of their molecules..Let your wisdom offer it to you!
$1.1 billion Martek sale measures success of UMD-Mtech ‘grads’ The latest success of Martek Biosciences, a rising-star among Maryland biotechs, began more than a decade ago in an ordinary, brick building on the University of Maryland campus. With a good idea and early-stage nurturing from the university’s Maryland Technology Business Institute , the ongoing company has had the opportunity to grow right into a major international business. On 21 December, a Dutch firm acquired Martek for $1.1 billion < - the latest in a string of successes for Mtech alums.